Clinical Trial

Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)

Study acronym: REVIU48
Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, multicenter, non-interventional study conducted over 6 months, including patients presenting to the emergency department with suspected urinary tract infection managed as outpatients and discharged with or without empiric antibiotic therapy. Discharge antibiotic prescriptions are reviewed, with subsequent reassessment and optimization of treatment based on urine culture and susceptibility results
Protocol Amendment History 2 changes
critical Recruitment opened 2026-06-13
notable Trial sites expanded: 0 -> 3 locations 2026-06-13
Trial Details
NCT Number NCT07559318
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Conditions Urinary Tract Infections, Antiobiotic Stewardship, Emerging Infectious Disease
Enrollment 330 participants
Start Date 2026-06-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-12